For side effects, who should not use it, and FDA compounding information, open the safety FAQ below
The World Health Organization (WHO) and other experts say more research is needed
J Physiol Paris 93:479485 Sikiric P, Seiwerth S, Brcic L, Blagaic AB, Zoricic I, Sever M, Klicek R, Radic B, Keller N, Sipos K et al (2006) Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL 14736, Pliva, Croatia)
Beyond collagen, GHK-Cus effects on the extracellular matrix extend to elastin (30% increase), decorin (302% increase at 1 nanomolar concentration), glycosaminoglycans, dermatan sulfate, and chondroitin sulfate
The physician must be accessible